Financials Imricor Medical Systems, Inc.

Equities

IMR

AU0000054942

Advanced Medical Equipment & Technology

Delayed Australian S.E. 12:57:01 2024-04-26 am EDT 5-day change 1st Jan Change
0.49 AUD -2.00% Intraday chart for Imricor Medical Systems, Inc. -4.85% -14.04%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 77.83 218.3 104.5 37.64 65.57 64.73 - -
Enterprise Value (EV) 1 77.83 194.3 86.55 32.62 65.57 53.03 51.03 65.53
P/E ratio -3.8 x - -4.86 x -2.07 x -2.77 x -4.84 x -6.27 x -10.7 x
Yield - - - - - - - -
Capitalization / Revenue 122 x 311 x 150 x 46.1 x - 17 x 7.41 x 3.7 x
EV / Revenue 122 x 277 x 124 x 40 x - 13.9 x 5.84 x 3.75 x
EV / EBITDA - -17 x -4.42 x -1.97 x - -3.93 x -4.56 x -10.1 x
EV / FCF - -15 x -4.78 x -1.95 x - -3.93 x -3.93 x -6.9 x
FCF Yield - -6.68% -20.9% -51.3% - -25.5% -25.5% -14.5%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 93,022 125,550 143,235 151,348 168,918 202,552 - -
Reference price 2 0.8366 1.739 0.7296 0.2487 0.3882 0.3196 0.3196 0.3196
Announcement Date 2/19/20 2/24/21 2/23/22 2/22/23 2/28/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 0.6397 0.7022 0.6963 0.816 - 3.81 8.74 17.48
EBITDA 1 - -11.43 -19.57 -16.55 - -13.5 -11.2 -6.5
EBIT 1 - -11.96 -20.26 -17.26 - -14 -11.7 -7.1
Operating Margin - -1,702.78% -2,909.7% -2,115.18% - -367.45% -133.87% -40.62%
Earnings before Tax (EBT) 1 - - -19.73 -17.36 - -14 -11.5 -6.8
Net income 1 - -12.45 -19.73 -17.36 -22.63 -14 -11.5 -6.8
Net margin - -1,772.6% -2,834.04% -2,126.97% - -367.45% -131.58% -38.9%
EPS 2 -0.2200 - -0.1500 -0.1200 -0.1400 -0.0660 -0.0510 -0.0300
Free Cash Flow 1 - -12.97 -18.11 -16.75 - -13.5 -13 -9.5
FCF margin - -1,847.52% -2,601.62% -2,052.56% - -354.33% -148.74% -54.35%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 2/19/20 2/24/21 2/23/22 2/22/23 2/28/24 - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - 0.8
Net Cash position 1 - 24 18 5.02 - 11.7 13.7 -
Leverage (Debt/EBITDA) - - - - - - - -0.1231 x
Free Cash Flow 1 - -13 -18.1 -16.7 - -13.5 -13 -9.5
ROE (net income / shareholders' equity) - -69.4% -77.1% -116% - - - -
ROA (Net income/ Total Assets) - -56.5% -65.3% -85.6% - -117% -76.2% -196%
Assets 1 - 22.05 30.22 20.28 - 11.96 15.09 3.471
Book Value Per Share - - - - - - - -
Cash Flow per Share 2 - - - - - -0.0700 -0.0600 -0.0400
Capex 1 - 0.74 0.63 0.24 - 0.7 0.5 0.5
Capex / Sales - 105.66% 89.87% 29.27% - 18.37% 5.72% 2.86%
Announcement Date 2/19/20 2/24/21 2/23/22 2/22/23 2/28/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3196 USD
Average target price
0.616 USD
Spread / Average Target
+92.77%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. IMR Stock
  4. Financials Imricor Medical Systems, Inc.